Fewer surgeries may be needed for bladder cancer thanks to new blood test


Thanks to a new blood test, patients with bladder cancer may be able to circumvent a precautionary cystectomy after treatment with immunotherapy. Scientists at the Netherlands Cancer Institute have shown that a new technique can improve the prediction of whether the tumor will recur. 

The findings by Jeroen van Dorp, Michiel van der Heijden, and Bas van Rhijn, in collaboration with the Cambridge-based company Inivata, have been published in the scientific journal Nature Medicine

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.